Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Corneal Endothelial Dystrophy Market Report 2025

Corneal Endothelial Dystrophy Global Market Report 2025 - By Treatment (Phototherapeutic Keratectomy, Amniotic Membrane Transplants, Anterior Stromal Puncture, Conjunctival Flaps), By Disease Type (Congenital Hereditary Endothelial Dystrophy 1, Congenital Hereditary Endothelial Dystrophy 2, Posterior Polymorphous Corneal Dystrophy, Fuchs Endothelial Corneal Dystrophy), By Diagnosis (Cornea Examination And Grading, Corneal Tomography, Corneal Pachymetry, Corneal Cell Count), By End-User (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Corneal Endothelial Dystrophy Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Corneal Endothelial Dystrophy Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Corneal Endothelial Dystrophy Market

Corneal endothelial dystrophy is a genetic eye disorder that affects the cornea's endothelium (the inner layer of cells), leading to progressive loss of corneal clarity. The condition is characterized by the degeneration of the endothelial cells responsible for maintaining proper fluid balance within the cornea.

The main types of treatments for the corneal endothelial dystrophy are phototherapeutic keratectomy (PTK), Amniotic Membrane Transplants, anterior stromal puncture, and conjunctival flaps. PTK is a laser procedure that removes superficial corneal layers to treat surface irregularities or scarring. These treatments are used for various disease types, including congenital hereditary endothelial dystrophy 1, congenital hereditary endothelial dystrophy 2, posterior polymorphous corneal dystrophy, and Fuchs' endothelial corneal dystrophy. Diagnosis methods include corneal examination and grading, corneal tomography, corneal pachymetry, and corneal cell count. The treatments are utilized by various end-users, including hospitals, clinics, and other healthcare facilities.

How Is The Corneal Endothelial Dystrophy Market Segmented?

The corneal endothelial dystrophy market covered in this report is segmented –

1) By Treatment: Phototherapeutic Keratectomy, Amniotic Membrane Transplants, Anterior Stromal Puncture, Conjunctival Flaps

2) By Disease Type: Congenital Hereditary Endothelial Dystrophy 1, Congenital Hereditary Endothelial Dystrophy 2, Posterior Polymorphous Corneal Dystrophy, Fuchs Endothelial Corneal Dystrophy

3) By Diagnosis: Cornea Examination And Grading, Corneal Tomography, Corneal Pachymetry, Corneal Cell Count

4) By End-User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Phototherapeutic Keratectomy: Excimer Laser Therapy, Corneal Reshaping

2) By Amniotic Membrane Transplants: Fresh Amniotic Membrane Transplant, Cryopreserved Amniotic Membrane Transplant

3) By Anterior Stromal Puncture: Manual Technique, Laser-Assisted Technique

4) By Conjunctival Flaps: Partial Flap Technique, Full Flap Technique

Corneal Endothelial Dystrophy Market Size and growth rate 2025 to 2029: Graph

What Is The Corneal Endothelial Dystrophy Market Size 2025 And Growth Rate?

The corneal endothelial dystrophy market size has grown strongly in recent years. It will grow from $170.96 billion in 2024 to $185.38 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growing healthcare expenditures, rise in the prevalence of such endothelial corneal dystrophy, growing aging population, increasing prevalence of eye diseases, and surge in prevalence of corneal disorders.

What Is The Corneal Endothelial Dystrophy Market Growth Forecast?

The corneal endothelial dystrophy market size is expected to see strong growth in the next few years. It will grow to $252.88 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rise in corneal blindness in emerging economies, increasing awareness about eye care, demand for corneal transplantation, rise in healthcare infrastructure, and increasing prevalence of chronic disorders. Major trends in the forecast period include advancements in regenerative therapies, advancement in medical technology, advancements in diagnostic techniques, technological advancements in ophthalmic lasers, and advanced technologies.

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Corneal Endothelial Dystrophy Market: Growing Demand For Corneal Transplantation Driving The Market

The growing demand for corneal transplantation is expected to drive the growth of the corneal endothelial dystrophy market going forward. Corneal transplantation is a surgical procedure in which a damaged or diseased cornea is replaced with a healthy donor cornea to restore vision and improve eye health. The demand for corneal transplantations is due to the rising prevalence of corneal diseases, advancements in surgical techniques, and improved organ donation rates. Corneal endothelial dystrophy is treated with corneal transplantation, which replaces the damaged endothelium with healthy donor tissue to restore corneal clarity, reduce edema, and improve vision. For instance, in 2023, according to the Eye Bank Association of America, a US-based transplant association, domestic keratoplasty (a form of corneal transplantation) procedures increased by 2.7%, rising from 49,597 in 2022 to 50,925 in 2023. Therefore, the growing demand for corneal transplantation is driving the growth of the corneal endothelial dystrophy market.

Who Are The Major Players In The Global Corneal Endothelial Dystrophy Market?

Major companies operating in the corneal endothelial dystrophy market are F. Hoffmann-La Roche AG, Abbvie (Allergan plc), Teva Pharmaceutical Industries Ltd, Fujifilm Holdings Corporation, Alcon Inc., Bausch Health+Lomb, Santen Pharmaceutical Co., Ltd., AGC Biologics Inc, Lumenis Ltd, Aurion Biotech Inc, Carl Zeiss Meditec AG, Keeler Limited, Kowa Company Ltd., ProQR Therapeutics N.V., Cellusion Inc., OptoTech GmbH, ActualEyes Inc., Arctic Vision Inc., Aurion Biotech LLC, Emmecell S.R.L

What Are The Key Trends Of The Global Corneal Endothelial Dystrophy Market: Development Of Innovative Treatments In Market

Major companies operating in the corneal endothelial dystrophy market are focusing on developing innovative treatments, such as allogeneic cell therapy, to address unmet medical needs by offering innovative, minimally invasive treatment options that improve patient outcomes. Allogeneic cell therapy refers to using cells from a donor of the same species but genetically distinct to treat a recipient. For instance, in September 2024, Aurion Biotech Inc., a US-based clinical-stage biotech company, launched Vyznova (neltependocel) in Japan to treat bullous keratopathy, a corneal endothelial disease. Vyznova (neltependocel) is a cell therapy developed by Aurion Biotech to treat bullous keratopathy, which damages the corneal endothelial cells and causes vision problems. It is the first approved cell therapy for corneal endothelial disease and has been approved in Japan. Vyznova uses corneal endothelial cells grown in a lab, allowing up to 1,000 doses to be made from a single donor. This innovative treatment offers a less invasive alternative to corneal transplants, helping address the shortage of donor corneas and providing a new way to restore vision for patients with corneal diseases.

What Are Latest Mergers And Acquisitions In The Corneal Endothelial Dystrophy Market: Eversight Partners With Emmecell To Advance Cell Therapies For Corneal Endothelial Diseases

In February 2024, Eversight, a US-based nonprofit eye bank, partnered with Emmecell. With this partnership, Eversight and Emmecell aim to advance minimally invasive cell therapies to treat corneal endothelial diseases, including corneal edema caused by endothelial cell dysfunction, and expand access to innovative treatments worldwide. Emmecell is a US-based biotechnology company developing a non-surgical cell therapy for corneal edema, often caused by corneal endothelial dysfunction.

What Is The Regional Outlook For The Global Corneal Endothelial Dystrophy Market?

North America was the largest region in the corneal endothelial dystrophy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the corneal endothelial dystrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the corneal endothelial dystrophy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Corneal Endothelial Dystrophy  Market?

The corneal endothelial dystrophy market consists of revenues earned by entities by providing services such as endothelial keratoplasty, specialized contact lenses, and penetrating keratoplasty. The market value includes the value of related goods sold by the service provider or included within the service offering. The corneal endothelial dystrophy market also includes sales of medications, corneal implants, surgical instruments, diagnostic devices, cell therapy products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Corneal Endothelial Dystrophy  Industry?

The corneal endothelial dystrophy market research report is one of a series of new reports from The Business Research Company that provides corneal endothelial dystrophy market statistics, including the corneal endothelial dystrophy industry global market size, regional shares, competitors with the corneal endothelial dystrophy market share, detailed corneal endothelial dystrophy market segments, market trends, and opportunities, and any further data you may need to thrive in the corneal endothelial dystrophy industry. This corneal endothelial dystrophy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Corneal Endothelial Dystrophy Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $185.38 billion
Revenue Forecast In 2034 $252.88 billion
Growth Rate CAGR of 8.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The corneal endothelial dystrophy market covered in this report is segmented –
1) By Treatment: Phototherapeutic Keratectomy, Amniotic Membrane Transplants, Anterior Stromal Puncture, Conjunctival Flaps
2) By Disease Type: Congenital Hereditary Endothelial Dystrophy 1, Congenital Hereditary Endothelial Dystrophy 2, Posterior Polymorphous Corneal Dystrophy, Fuchs Endothelial Corneal Dystrophy
3) By Diagnosis: Cornea Examination And Grading, Corneal Tomography, Corneal Pachymetry, Corneal Cell Count
4) By End-User: Hospitals, Clinics, Other End Users Subsegments:
1) By Phototherapeutic Keratectomy: Excimer Laser Therapy, Corneal Reshaping
2) By Amniotic Membrane Transplants: Fresh Amniotic Membrane Transplant, Cryopreserved Amniotic Membrane Transplant
3) By Anterior Stromal Puncture: Manual Technique, Laser-Assisted Technique
4) By Conjunctival Flaps: Partial Flap Technique, Full Flap Technique
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG, Abbvie (Allergan plc), Teva Pharmaceutical Industries Ltd, Fujifilm Holdings Corporation, Alcon Inc., Bausch Health+Lomb, Santen Pharmaceutical Co., Ltd., AGC Biologics Inc, Lumenis Ltd, Aurion Biotech Inc, Carl Zeiss Meditec AG, Keeler Limited, Kowa Company Ltd., ProQR Therapeutics N.V., Cellusion Inc., OptoTech GmbH, ActualEyes Inc., Arctic Vision Inc., Aurion Biotech LLC, Emmecell S.R.L
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Corneal Endothelial Dystrophy Market Characteristics

    3. Corneal Endothelial Dystrophy Market Trends And Strategies

    4. Corneal Endothelial Dystrophy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Corneal Endothelial Dystrophy Growth Analysis And Strategic Analysis Framework

    5.1. Global Corneal Endothelial Dystrophy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Corneal Endothelial Dystrophy Market Growth Rate Analysis

    5.4. Global Corneal Endothelial Dystrophy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Corneal Endothelial Dystrophy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Corneal Endothelial Dystrophy Total Addressable Market (TAM)

    6. Corneal Endothelial Dystrophy Market Segmentation

    6.1. Global Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Phototherapeutic Keratectomy

    Amniotic Membrane Transplants

    Anterior Stromal Puncture

    Conjunctival Flaps

    6.2. Global Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Congenital Hereditary Endothelial Dystrophy 1

    Congenital Hereditary Endothelial Dystrophy 2

    Posterior Polymorphous Corneal Dystrophy

    Fuchs Endothelial Corneal Dystrophy

    6.3. Global Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cornea Examination And Grading

    Corneal Tomography

    Corneal Pachymetry

    Corneal Cell Count

    6.4. Global Corneal Endothelial Dystrophy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Other End Users

    6.5. Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Phototherapeutic Keratectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Excimer Laser Therapy

    Corneal Reshaping

    6.6. Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Amniotic Membrane Transplants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Fresh Amniotic Membrane Transplant

    Cryopreserved Amniotic Membrane Transplant

    6.7. Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Anterior Stromal Puncture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Manual Technique

    Laser-Assisted Technique

    6.8. Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Conjunctival Flaps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Partial Flap Technique

    Full Flap Technique

    7. Corneal Endothelial Dystrophy Market Regional And Country Analysis

    7.1. Global Corneal Endothelial Dystrophy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Corneal Endothelial Dystrophy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Corneal Endothelial Dystrophy Market

    8.1. Asia-Pacific Corneal Endothelial Dystrophy Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Corneal Endothelial Dystrophy Market

    9.1. China Corneal Endothelial Dystrophy Market Overview

    9.2. China Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Corneal Endothelial Dystrophy Market

    10.1. India Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Corneal Endothelial Dystrophy Market

    11.1. Japan Corneal Endothelial Dystrophy Market Overview

    11.2. Japan Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Corneal Endothelial Dystrophy Market

    12.1. Australia Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Corneal Endothelial Dystrophy Market

    13.1. Indonesia Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Corneal Endothelial Dystrophy Market

    14.1. South Korea Corneal Endothelial Dystrophy Market Overview

    14.2. South Korea Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Corneal Endothelial Dystrophy Market

    15.1. Western Europe Corneal Endothelial Dystrophy Market Overview

    15.2. Western Europe Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Corneal Endothelial Dystrophy Market

    16.1. UK Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Corneal Endothelial Dystrophy Market

    17.1. Germany Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Corneal Endothelial Dystrophy Market

    18.1. France Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Corneal Endothelial Dystrophy Market

    19.1. Italy Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Corneal Endothelial Dystrophy Market

    20.1. Spain Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Corneal Endothelial Dystrophy Market

    21.1. Eastern Europe Corneal Endothelial Dystrophy Market Overview

    21.2. Eastern Europe Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Corneal Endothelial Dystrophy Market

    22.1. Russia Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Corneal Endothelial Dystrophy Market

    23.1. North America Corneal Endothelial Dystrophy Market Overview

    23.2. North America Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Corneal Endothelial Dystrophy Market

    24.1. USA Corneal Endothelial Dystrophy Market Overview

    24.2. USA Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Corneal Endothelial Dystrophy Market

    25.1. Canada Corneal Endothelial Dystrophy Market Overview

    25.2. Canada Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Corneal Endothelial Dystrophy Market

    26.1. South America Corneal Endothelial Dystrophy Market Overview

    26.2. South America Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Corneal Endothelial Dystrophy Market

    27.1. Brazil Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Corneal Endothelial Dystrophy Market

    28.1. Middle East Corneal Endothelial Dystrophy Market Overview

    28.2. Middle East Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Corneal Endothelial Dystrophy Market

    29.1. Africa Corneal Endothelial Dystrophy Market Overview

    29.2. Africa Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Corneal Endothelial Dystrophy Market Competitive Landscape And Company Profiles

    30.1. Corneal Endothelial Dystrophy Market Competitive Landscape

    30.2. Corneal Endothelial Dystrophy Market Company Profiles

    30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Abbvie (Allergan plc) Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Corneal Endothelial Dystrophy Market Other Major And Innovative Companies

    31.1. Bausch Health+Lomb

    31.2. Santen Pharmaceutical Co., Ltd.

    31.3. AGC Biologics Inc

    31.4. Lumenis Ltd

    31.5. Aurion Biotech Inc

    31.6. Carl Zeiss Meditec AG

    31.7. Keeler Limited

    31.8. Kowa Company Ltd.

    31.9. ProQR Therapeutics N.V.

    31.10. Cellusion Inc.

    31.11. OptoTech GmbH

    31.12. ActualEyes Inc.

    31.13. Arctic Vision Inc.

    31.14. Aurion Biotech LLC

    31.15. Emmecell S.R.L

    32. Global Corneal Endothelial Dystrophy Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Corneal Endothelial Dystrophy Market

    34. Recent Developments In The Corneal Endothelial Dystrophy Market

    35. Corneal Endothelial Dystrophy Market High Potential Countries, Segments and Strategies

    35.1 Corneal Endothelial Dystrophy Market In 2029 - Countries Offering Most New Opportunities

    35.2 Corneal Endothelial Dystrophy Market In 2029 - Segments Offering Most New Opportunities

    35.3 Corneal Endothelial Dystrophy Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Corneal Endothelial Dystrophy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Phototherapeutic Keratectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Amniotic Membrane Transplants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Anterior Stromal Puncture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Conjunctival Flaps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Corneal Endothelial Dystrophy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Corneal Endothelial Dystrophy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: F. Hoffmann-La Roche AG Financial Performance
  • Table 80: Abbvie (Allergan plc) Financial Performance
  • Table 81: Teva Pharmaceutical Industries Ltd Financial Performance
  • Table 82: Fujifilm Holdings Corporation Financial Performance
  • Table 83: Alcon Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Corneal Endothelial Dystrophy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Phototherapeutic Keratectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Amniotic Membrane Transplants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Anterior Stromal Puncture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Conjunctival Flaps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Corneal Endothelial Dystrophy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Corneal Endothelial Dystrophy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: F. Hoffmann-La Roche AG Financial Performance
  • Figure 80: Abbvie (Allergan plc) Financial Performance
  • Figure 81: Teva Pharmaceutical Industries Ltd Financial Performance
  • Figure 82: Fujifilm Holdings Corporation Financial Performance
  • Figure 83: Alcon Inc. Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

Read More

What Is The Healthcare IT Consulting Market Overview In 2022?

Read More

How Will The Stem Cell Assay Market Grow In 2022?

Read More

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Read More

Corneal Implants Global Market Report 2025 – By Implant Type (Artificial Corneal Implant, Human Corneal Implant), By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Other Procedure Types), By Application (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, Other Applications), By End-User (Hospitals, Ophthalmic Center, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2025 – By Drugs Type (Avastin, Tecentriq, Lucentis, Tagrisso, Cometriq, Eylea, Other Drug Types), By Route Of Administration (Oral, Intravenous, Intravitreal), By Application (Oncology, Ophthalmology, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025 – By Product (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration), By End Users (Hospitals, Clinics, Oncology Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Duchenne Muscular Dystrophy Global Market Report 2025 – By Therapy (Mutation Suppression, Exon Skipping Approach), By Therapeutic Class (Molecular Based Therapies, Steroid Therapy), By Route of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Duchenne Muscular Dystrophy (DMD) Therapeutics Global Market Report 2025 – By Type (Small Molecules, Biologics), By Distribution Channel (Offline, Online), By Application (Hospitals, Clinics, Home Care) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Minimal Residual Disease Testing Global Market Report 2025 – By Test Type (DNA - Based Test, RNA- Based Test, Immunological Test), By Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies ), By Application (Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application), By End User (Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic and Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2025 – By Drug Class (Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, Other Drug Classes), By Type (Chronic Bronchitis, Emphysema), By End-User (Hospitals, Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Respiratory Disease Testing Global Market Report 2025 – By Test Type (Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests), By Products (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products), By Application (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis Female, Other Application), By End-User (Hospitals, Physician clinics, Clinical laboratories, Other End-User) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Corneal Endothelial Dystrophy market?

Corneal endothelial dystrophy is a genetic eye disorder that affects the cornea's endothelium (the inner layer of cells), leading to progressive loss of corneal clarity. The condition is characterized by the degeneration of the endothelial cells responsible for maintaining proper fluid balance within the cornea. For further insights on the Corneal Endothelial Dystrophy market, request a sample here

How will the Corneal Endothelial Dystrophy market drivers and restraints affect the market dynamics? What forces will shape the Corneal Endothelial Dystrophy industry going forward?

The Corneal Endothelial Dystrophy market major growth driver - Growing Demand For Corneal Transplantation Driving The Market. For further insights on the Corneal Endothelial Dystrophy market, request a sample here

What is the forecast market size or the forecast market value of the Corneal Endothelial Dystrophy market?

The Corneal Endothelial Dystrophy market size has grown strongly in recent years. The corneal endothelial dystrophy market size has grown strongly in recent years. It will grow from $170.96 billion in 2024 to $185.38 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growing healthcare expenditures, rise in the prevalence of such endothelial corneal dystrophy, growing aging population, increasing prevalence of eye diseases, and surge in prevalence of corneal disorders. The corneal endothelial dystrophy market size is expected to see strong growth in the next few years. It will grow to $252.88 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rise in corneal blindness in emerging economies, increasing awareness about eye care, demand for corneal transplantation, rise in healthcare infrastructure, and increasing prevalence of chronic disorders. Major trends in the forecast period include advancements in regenerative therapies, advancement in medical technology, advancements in diagnostic techniques, technological advancements in ophthalmic lasers, and advanced technologies. For further insights on the Corneal Endothelial Dystrophy market, request a sample here

How is the Corneal Endothelial Dystrophy market segmented?

The corneal endothelial dystrophy market covered in this report is segmented –
1) By Treatment: Phototherapeutic Keratectomy, Amniotic Membrane Transplants, Anterior Stromal Puncture, Conjunctival Flaps
2) By Disease Type: Congenital Hereditary Endothelial Dystrophy 1, Congenital Hereditary Endothelial Dystrophy 2, Posterior Polymorphous Corneal Dystrophy, Fuchs Endothelial Corneal Dystrophy
3) By Diagnosis: Cornea Examination And Grading, Corneal Tomography, Corneal Pachymetry, Corneal Cell Count
4) By End-User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Phototherapeutic Keratectomy: Excimer Laser Therapy, Corneal Reshaping
2) By Amniotic Membrane Transplants: Fresh Amniotic Membrane Transplant, Cryopreserved Amniotic Membrane Transplant
3) By Anterior Stromal Puncture: Manual Technique, Laser-Assisted Technique
4) By Conjunctival Flaps: Partial Flap Technique, Full Flap Technique For further insights on the Corneal Endothelial Dystrophy market, request a sample here

Which region has the largest share of the Corneal Endothelial Dystrophy market? What are the other regions covered in the report?

North America was the largest region in the corneal endothelial dystrophy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the corneal endothelial dystrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Corneal Endothelial Dystrophy market, request a sample here.

Who are the major players in the Corneal Endothelial Dystrophy market?

Major companies operating in the corneal endothelial dystrophy market are F. Hoffmann-La Roche AG, Abbvie (Allergan plc), Teva Pharmaceutical Industries Ltd, Fujifilm Holdings Corporation, Alcon Inc., Bausch Health+Lomb, Santen Pharmaceutical Co., Ltd., AGC Biologics Inc, Lumenis Ltd, Aurion Biotech Inc, Carl Zeiss Meditec AG, Keeler Limited, Kowa Company Ltd., ProQR Therapeutics N.V., Cellusion Inc., OptoTech GmbH, ActualEyes Inc., Arctic Vision Inc., Aurion Biotech LLC, Emmecell S.R.L . For further insights on the Corneal Endothelial Dystrophy market, request a sample here.

What are the key trends in the Corneal Endothelial Dystrophy market?

Major trends in the Corneal Endothelial Dystrophy market include Development Of Innovative Treatments In Market. For further insights on the Corneal Endothelial Dystrophy market, request a sample here.

What are the major opportunities in the Corneal Endothelial Dystrophy market? What are the strategies for the Corneal Endothelial Dystrophy market?

For detailed insights on the major opportunities and strategies in the Corneal Endothelial Dystrophy market, request a sample here.

How does the Corneal Endothelial Dystrophy market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Corneal Endothelial Dystrophy market growth and SWOT analysis of the Corneal Endothelial Dystrophy industry, request a sample here.

For detailed insights on Corneal Endothelial Dystrophy's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Corneal Endothelial Dystrophy industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Corneal Endothelial Dystrophy industry,

What are the key dynamics influencing the Corneal Endothelial Dystrophy market growth? SWOT analysis of the Corneal Endothelial Dystrophy market. request a sample here.